California scientists took what looked like an $800 million hit last week in their efforts to develop revolutionary ...

In parts of the world where traveling to a clinic for routine blood tests is a financial and logistical challenge, HIV ...

Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Inotiv (NOTV – Research Report) today. The company’s shares closed last Friday at ...

The successful integration of AI into nanoparticle analysis has profound implications across multiple scientific and ...

CVRx , Inc. (NASDAQ:CVRX), a medical device company with a market capitalization of $382 million specializing in the development and commercialization of the Barostim therapy for heart failure and ...

Clearside Biomedical, Inc. (NASDAQ:CLSD), currently valued at $81.15 million, is a biotechnology company focused on developing innovative therapies for blinding eye diseases using its proprietary SCS ...

A research team led by Professor Kevin Tsia, programme director of the Biomedical Engineering Programme under the Faculty of Engineering of the University of Hong Kong (HKU), has developed an ...

The human body is a key subject of research by scientists worldwide. A biomedical engineering research team led by Professor ...

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.

The advent of smart biomedical signal analysis systems marks a significant leap forward, enabling continuous monitoring of disease progression and providing unprecedented insights into patients’ ...

The College of Biomedical and Life Sciences is a vibrant academic community, which undertakes innovative research and provides state-of-the-art learning facilities. Researchers from Cardiff University ...